1h Free Analyst Time
Speak directly to the analyst to clarify any post sales queries you may have.
The third-party pathology diagnostics market is evolving rapidly, shaped by the convergence of scientific breakthroughs and dynamic healthcare requirements. As independent laboratories increasingly underpin precision medicine and value-based care, market complexity and opportunity are both accelerating.
Market Snapshot: Third-Party Pathology Diagnostics
Valued at USD [data unavailable] in 2023 and projected to reach USD [data unavailable] by 2028, the global third-party pathology diagnostics market is expanding at a CAGR of [data unavailable]%. This growth is driven by rising demand for specialized laboratory services, integration of digital and molecular platforms, and the strategic repositioning of diagnostics as a core healthcare component.
Scope & Segmentation of the Third-Party Pathology Diagnostics Market
This report delivers a comprehensive analysis across key segments, technology platforms, applications, regions, and leading companies:
- Service Types: Anatomic Pathology, Clinical Pathology, Cytogenetics, Microbiology, Molecular Pathology (including Fluorescence In Situ Hybridization, Next Generation Sequencing, Targeted Next Generation Sequencing, Whole Exome Sequencing, Whole Genome Sequencing, and Polymerase Chain Reaction)
- Technologies: Digital Pathology, Flow Cytometry, Immunohistochemistry, Next Generation Sequencing
- Applications: Cardiology, Gastroenterology, Infectious Diseases, Neurology, Oncology
- End Users: Academic & Research Institutes, Clinics, Diagnostic Laboratories, Hospitals
- Sample Types: Blood, Tissue, Urine
- Delivery Modes: Inhouse, Outsourced
- Regional Coverage: Americas (including major U.S. states and countries such as Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including UK, Germany, France, Russia, Italy, UAE, Saudi Arabia, South Africa, and more), Asia-Pacific (notably China, India, Japan, Australia, South Korea, and Southeast Asian markets)
- Companies Covered: Quest Diagnostics Incorporated, Sonic Healthcare Limited, Eurofins Scientific SE, Synlab International GmbH, Unilabs SA, OPKO Health, Inc., SRL Diagnostics Private Limited, Cerba Healthcare SA, Fulgent Genetics, Inc.
Key Takeaways for Senior Decision-Makers
- Artificial intelligence and high-throughput sequencing are reshaping laboratory workflows, advancing diagnostic precision and operational scalability.
- Telepathology adoption widens specialized access, improving care delivery in both central and underserved regions.
- Strategic partnerships—ranging from reagent manufacturers to academic collaborations—are critical for sustained differentiation and innovation.
- Segment diversification, from targeted molecular diagnostics to traditional pathology, allows laboratories to tailor offerings to clinical trends and evolving demands.
- Supply chain resiliency and digital infrastructure investment enable responsive adaptation to regulatory and market fluctuations.
- Integration of cloud-based systems and remote consultation enhances interoperability, clinician engagement, and overall patient care outcomes.
Tariff Impact: Navigating the Shifting U.S. Regulatory Landscape
Recent U.S. tariff adjustments have placed pressure on centers reliant on imported reagents and instrumentation, prompting transitions to alternative procurement channels. Laboratories are mitigating cost volatility by optimizing inventory management, negotiating bulk agreements, and exploring domestic production partners. These regulatory shifts also accelerate the uptake of modular automation and multiplexed assays to absorb increased input costs while maintaining service quality. Communication with healthcare providers and payers has become vital in navigating price adjustments and retaining trust.
Primary Keyword Use in Diagnostics Market Analysis
Methodology & Data Sources
This report employs robust multi-stage research, including comprehensive secondary reviews, in-depth interviews with laboratory and technology leaders, and validation through triangulated analysis of financial statements, regulatory data, and scientific literature. Expert synthesis workshops underpin the reliability and relevance of key findings.
Why This Report Matters
- Supports executive decision-making by distilling critical trends, innovative pathways, and competitive positioning across the third-party pathology diagnostics market.
- Empowers organizations to optimize strategy by clarifying the effects of regulatory shifts and highlighting emerging growth segments.
- Enables risk mitigation and resource allocation through actionable insights into supply chains, reimbursement frameworks, and regional investment dynamics.
Conclusion
The third-party pathology diagnostics market is at a pivotal juncture, driven by technology adoption, regulatory evolution, and new care delivery models. Leaders who embrace collaborative strategies and innovation will be best positioned to advance precision medicine and capture emerging opportunities.
This product will be delivered within 1-3 business days.
Table of Contents
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of AI-driven histopathology image analysis platforms for improved diagnostic accuracy and workflow efficiency
5.2. Rising demand for outsourced genomic sequencing services to support precision oncology and personalized medicine initiatives
5.3. Expansion of telepathology consultations enabling remote expert review and collaborative diagnosis across geographies
5.4. Growing adoption of digital slide scanning technology to streamline specimen management and archival processes
5.5. Implementation of cloud-based laboratory information management systems for enhanced data integration and accessibility
5.6. Regulatory shift towards tougher quality standards in pathology labs driving investments in accreditation and compliance
5.7. Demand surge for infectious disease testing capabilities following global pandemic preparedness and monitoring efforts
5.8. Partnerships between pathology centers and pharmaceutical firms to accelerate biomarker discovery in clinical trials
5.2. Rising demand for outsourced genomic sequencing services to support precision oncology and personalized medicine initiatives
5.3. Expansion of telepathology consultations enabling remote expert review and collaborative diagnosis across geographies
5.4. Growing adoption of digital slide scanning technology to streamline specimen management and archival processes
5.5. Implementation of cloud-based laboratory information management systems for enhanced data integration and accessibility
5.6. Regulatory shift towards tougher quality standards in pathology labs driving investments in accreditation and compliance
5.7. Demand surge for infectious disease testing capabilities following global pandemic preparedness and monitoring efforts
5.8. Partnerships between pathology centers and pharmaceutical firms to accelerate biomarker discovery in clinical trials
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
6.2. PESTLE Analysis
8. Third-party Pathology Diagnosis Center Market, by Service Type
8.1. Introduction
8.2. Anatomic Pathology
8.3. Clinical Pathology
8.4. Cytogenetics
8.5. Microbiology
8.6. Molecular Pathology
8.6.1. Fluorescence in Situ Hybridization
8.6.2. Next Generation Sequencing
8.6.2.1. Targeted Next Generation Sequencing
8.6.2.2. Whole Exome Sequencing
8.6.2.3. Whole Genome Sequencing
8.6.3. Polymerase Chain Reaction
8.2. Anatomic Pathology
8.3. Clinical Pathology
8.4. Cytogenetics
8.5. Microbiology
8.6. Molecular Pathology
8.6.1. Fluorescence in Situ Hybridization
8.6.2. Next Generation Sequencing
8.6.2.1. Targeted Next Generation Sequencing
8.6.2.2. Whole Exome Sequencing
8.6.2.3. Whole Genome Sequencing
8.6.3. Polymerase Chain Reaction
9. Third-party Pathology Diagnosis Center Market, by Technology
9.1. Introduction
9.2. Digital Pathology
9.3. Flow Cytometry
9.4. Immunohistochemistry
9.5. Next Generation Sequencing
9.2. Digital Pathology
9.3. Flow Cytometry
9.4. Immunohistochemistry
9.5. Next Generation Sequencing
10. Third-party Pathology Diagnosis Center Market, by Application
10.1. Introduction
10.2. Cardiology
10.3. Gastroenterology
10.4. Infectious Diseases
10.5. Neurology
10.6. Oncology
10.2. Cardiology
10.3. Gastroenterology
10.4. Infectious Diseases
10.5. Neurology
10.6. Oncology
11. Third-party Pathology Diagnosis Center Market, by End User
11.1. Introduction
11.2. Academic & Research Institutes
11.3. Clinics
11.4. Diagnostic Laboratories
11.5. Hospitals
11.2. Academic & Research Institutes
11.3. Clinics
11.4. Diagnostic Laboratories
11.5. Hospitals
12. Third-party Pathology Diagnosis Center Market, by Sample Type
12.1. Introduction
12.2. Blood
12.3. Tissue
12.4. Urine
12.2. Blood
12.3. Tissue
12.4. Urine
13. Third-party Pathology Diagnosis Center Market, by Delivery Mode
13.1. Introduction
13.2. Inhouse
13.3. Outsourced
13.2. Inhouse
13.3. Outsourced
14. Americas Third-party Pathology Diagnosis Center Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Third-party Pathology Diagnosis Center Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Third-party Pathology Diagnosis Center Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Quest Diagnostics Incorporated
17.3.2. Sonic Healthcare Limited
17.3.3. Eurofins Scientific SE
17.3.4. Synlab International GmbH
17.3.5. Unilabs SA
17.3.6. OPKO Health, Inc.
17.3.7. SRL Diagnostics Private Limited
17.3.8. Cerba Healthcare SA
17.3.9. Fulgent Genetics, Inc.
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Quest Diagnostics Incorporated
17.3.2. Sonic Healthcare Limited
17.3.3. Eurofins Scientific SE
17.3.4. Synlab International GmbH
17.3.5. Unilabs SA
17.3.6. OPKO Health, Inc.
17.3.7. SRL Diagnostics Private Limited
17.3.8. Cerba Healthcare SA
17.3.9. Fulgent Genetics, Inc.
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET: RESEARCHAI
FIGURE 28. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET: RESEARCHSTATISTICS
FIGURE 29. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET: RESEARCHCONTACTS
FIGURE 30. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET: RESEARCHARTICLES
FIGURE 2. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET: RESEARCHAI
FIGURE 28. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET: RESEARCHSTATISTICS
FIGURE 29. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET: RESEARCHCONTACTS
FIGURE 30. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ANATOMIC PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ANATOMIC PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOGENETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOGENETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TARGETED NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TARGETED NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INHOUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INHOUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY OUTSOURCED, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 120. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 121. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 122. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 123. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 124. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 125. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 134. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 138. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 139. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 140. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 141. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 217. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 220. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 221. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 222. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 223. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 230. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 231. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 232. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 233. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 235. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 236. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 237. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 238. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 239. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 248. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 265. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 266. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 267. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 268. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 269. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 270. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 271. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 278. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 279. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 280. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE,
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ANATOMIC PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ANATOMIC PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICAL PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOGENETICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CYTOGENETICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLUORESCENCE IN SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TARGETED NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TARGETED NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE EXOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY WHOLE GENOME SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIGITAL PATHOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CARDIOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY GASTROENTEROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEUROLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY BLOOD, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TISSUE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY URINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INHOUSE, BY REGION, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY INHOUSE, BY REGION, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY OUTSOURCED, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 119. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 120. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 121. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 122. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 123. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 124. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 125. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 126. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 127. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 128. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 129. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 130. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 131. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 132. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 133. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 134. CANADA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 135. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 136. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 137. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 138. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 139. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 140. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 141. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 142. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 143. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 144. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 145. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 146. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 147. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 148. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 149. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 151. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 152. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 153. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 154. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 155. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 156. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 157. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 158. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 159. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 160. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 161. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 167. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 168. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 169. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 170. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 171. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 172. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 173. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 174. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 175. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 176. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 177. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 180. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 181. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 182. ARGENTINA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 183. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 184. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 185. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 186. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 187. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 188. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 189. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 190. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 191. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 192. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 193. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 194. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 195. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 201. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 202. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 203. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 204. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 205. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 206. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 207. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 210. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 211. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 214. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 215. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 216. UNITED KINGDOM THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 217. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 218. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 219. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 220. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 221. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 222. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 223. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 224. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 225. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 226. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 227. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 230. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 231. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 232. GERMANY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 233. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 234. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 235. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 236. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 237. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 238. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 239. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 240. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 241. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 242. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 243. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 244. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 245. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 246. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 247. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 248. FRANCE THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 249. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 250. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 251. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 252. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 253. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 254. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 255. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 256. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 257. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 258. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 259. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 262. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 263. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 264. RUSSIA THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2025-2030 (USD MILLION)
TABLE 265. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2018-2024 (USD MILLION)
TABLE 266. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SERVICE TYPE, 2025-2030 (USD MILLION)
TABLE 267. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2018-2024 (USD MILLION)
TABLE 268. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY MOLECULAR PATHOLOGY, 2025-2030 (USD MILLION)
TABLE 269. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2018-2024 (USD MILLION)
TABLE 270. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY NEXT GENERATION SEQUENCING, 2025-2030 (USD MILLION)
TABLE 271. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 272. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 273. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
TABLE 274. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
TABLE 275. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 276. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 277. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
TABLE 278. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY SAMPLE TYPE, 2025-2030 (USD MILLION)
TABLE 279. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE, BY DELIVERY MODE, 2018-2024 (USD MILLION)
TABLE 280. ITALY THIRD-PARTY PATHOLOGY DIAGNOSIS CENTER MARKET SIZE,
Samples
LOADING...
Companies Mentioned
The companies profiled in this Third-party Pathology Diagnosis Center market report include:- Quest Diagnostics Incorporated
- Sonic Healthcare Limited
- Eurofins Scientific SE
- Synlab International GmbH
- Unilabs SA
- OPKO Health, Inc.
- SRL Diagnostics Private Limited
- Cerba Healthcare SA
- Fulgent Genetics, Inc.
